These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13853509)

  • 41. [Neurogenic vasodilatation caused by sympathomimetics].
    Osswald W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):67-80. PubMed ID: 4254220
    [No Abstract]   [Full Text] [Related]  

  • 42. [The treatment of peripheral arterial disease with 1-(4-hydroxyphenyl)-1-hydroxy-2-n-butylaminoethane sulfate].
    FORATTINI C; TOSO M
    Minerva Med; 1959 Nov; 50():3699-705. PubMed ID: 13823865
    [No Abstract]   [Full Text] [Related]  

  • 43. [Experimental research on the action of 1-(p-hydroxyphenyl)-2-(n-butylamino)-ethanol on the process of fracture healing].
    CUCCINOTTA U; CATANIA E
    Riv Patol Clin; 1961 Jul; 16():343-50. PubMed ID: 13882558
    [No Abstract]   [Full Text] [Related]  

  • 44. [Experimental study of the hypertensive properties of 3-iodo- and 3,5-diiodo-4-hydroxyphenyl-N-methyl ethanolamines].
    KLEPPING J; MICHEL R; TRON-LOISEL H; TRUCHOT R
    C R Seances Soc Biol Fil; 1960; 154():2001-5. PubMed ID: 13756775
    [No Abstract]   [Full Text] [Related]  

  • 45. [The treatment of prolonged erections using phenylephrine].
    Dittrich A; Vandendris M
    Acta Urol Belg; 1991; 59(3):69-74. PubMed ID: 1759668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the action of 1-(p-hydroxyphenyl)-2-(butylamino)-ethanol on the process of wound healing].
    CATANIA E
    Boll Soc Ital Biol Sper; 1960 Dec; 36():1425-7. PubMed ID: 13691530
    [No Abstract]   [Full Text] [Related]  

  • 47. The letrozole phase 1 metabolite carbinol as a novel probe drug for UGT2B7.
    Precht JC; Schroth W; Klein K; Brauch H; Krynetskiy E; Schwab M; Mürdter TE
    Drug Metab Dispos; 2013 Nov; 41(11):1906-13. PubMed ID: 23965986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Influence of 3- and 3,5-iodo-4-hydroxyphenyl-N-methyl ethanolamines on oxygen consumption of the normal and thyroidectomized rat].
    MICHEL R; KLEPPING J; TRUCHOT R; TRON-LOISEL H
    C R Seances Soc Biol Fil; 1960; 154():2006-9. PubMed ID: 13770251
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of m-hydroxyphenyl-ethanolethylamine in the care of the premature; clinical observations.
    ZANINI A
    Minerva Pediatr; 1959 Apr; 11(16):502-3. PubMed ID: 13666618
    [No Abstract]   [Full Text] [Related]  

  • 50. A new method for rapid determination of indole-3-carbinol and its condensation products in nutraceuticals using core-shell column chromatography method.
    Fibigr J; Šatínský D; Havlíková L; Solich P
    J Pharm Biomed Anal; 2016 Feb; 120():383-90. PubMed ID: 26795880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Proposals for the formulation of some articles of the German Pharmacopeia in the series on circulatory agents. II. Bromometric determination of 1-(m-hydroxyphenyl)-2-alkylamino-alkane-ols].
    AWE W; STOHLMANN H
    Pharm Zentralhalle Dtschl; 1957 Nov; 96(11):568-70. PubMed ID: 13494160
    [No Abstract]   [Full Text] [Related]  

  • 52. Photostability of symphatomimetic agents in commonly used infusion media in the absence and presence of bisulfite.
    Brustugun J; Kristensen S; Tønnesen HH
    PDA J Pharm Sci Technol; 2004; 58(6):296-308. PubMed ID: 15663061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Distribution of different groups of indirect sympathomimetics between aqueous and "fatty" phases].
    Granik VG; Al'tshuler RA; Persianova IV; Mashkovskiĭ MD; Sheĭnker IuN
    Farmakol Toksikol; 1977; 40(1):31-3. PubMed ID: 852543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapy of orthostatic dysregulation. Comparative studies on anti-hypotensive sympathomimetics with a tilt-table test].
    Lossnitzer K; Gäb J
    Fortschr Med; 1980 Aug; 98(29):(1133-6). PubMed ID: 6108908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of changes in molecular configuration on inhibitory sympathominetic action.
    LANDS AM; TAINTER ML
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 219(1-2):76-90. PubMed ID: 13099341
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolism of N-methyl-amide by cytochrome P450s: formation and characterization of highly stable carbinol-amide intermediate.
    Perrin L; Loiseau N; André F; Delaforge M
    FEBS J; 2011 Jun; 278(12):2167-78. PubMed ID: 21518254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stability of norepinephrine infusions prepared in dextrose and normal saline solutions.
    Tremblay M; Lessard MR; Trépanier CA; Nicole PC; Nadeau L; Turcotte G
    Can J Anaesth; 2008 Mar; 55(3):163-7. PubMed ID: 18310626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Angiolytic action of a synthetic adrenalin derivative (1-(p-hydroxyphenyl)-2-(n-butyl)-aminoethanol sulfate)].
    DISPENSA E; COCCO F
    Clin Ter; 1960 Dec; 19():602-20. PubMed ID: 13723078
    [No Abstract]   [Full Text] [Related]  

  • 59. [Kinetics of dimethophrine 7-3H or dl-1(3,5-dimethoxy-4-hydroxyphenyl-2-monomethylaminoethanol) in the rat].
    Scrollini F; Boselli P; Gervasi GB
    Boll Chim Farm; 1973; 112(6):391-400. PubMed ID: 4767640
    [No Abstract]   [Full Text] [Related]  

  • 60. [STUDIES ON SYMPATHOMIMETIC AMINES. VI. INVESTIGATION OF THE ACETYLATION METHOD].
    KISBYE J
    Dan Tidsskr Farm; 1964 Aug; 38():143-70. PubMed ID: 14222219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.